Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function
- 1 October 2002
- journal article
- Published by Elsevier in Brain Research
- Vol. 951 (2) , 166-176
- https://doi.org/10.1016/s0006-8993(02)03156-6
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Effects of Ketamine in Normal and Schizophrenic VolunteersPublished by Springer Nature ,2001
- Sequential Regional Cerebral Blood Flow Brain Scans Using PET with H215O Demonstrate Ketamine Actions in CNS DynamicallyNeuropsychopharmacology, 2001
- Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?Trends in Neurosciences, 2001
- Regional Neural Dysfunctions in Chronic Schizophrenia Studied With Positron Emission TomographyAmerican Journal of Psychiatry, 2000
- Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in RatsScience, 1998
- Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free SchizophrenicsNeuropsychopharmacology, 1997
- Ketamine activates psychosis and alters limbic blood flow in schizophreniaNeuroReport, 1995
- BRAIN IMAGING IN SCHIZOPHRENIAAnnual Review of Medicine, 1995
- Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal deathPublished by Elsevier ,1994
- A “Glutamatergic Hypothesis” of SchizophreniaClinical Neuropharmacology, 1989